Advanced Cell Technology, Inc. is a biotechnology company focused on developing and commercializing human embryonic and adult stem cell technology in the field of regenerative medicine. The Company's business is focused on both the development and commercialization of embryonic stem (ES) cell based technologies and adult stem cell transplantation therapies. Adult stem cell-based products are specifically targeted at therapies for heart and other cardiovascular disease and have received United States Food & Drug Administration (FDA) clearance to proceed to Phase II human clinical trials. The Company’s research efforts in human embryonic technologies are at the level of clinical trials, pre-clinical development and basic research.ACTC ACTC ACTC